HIV-specific CD8+ lymphocytes in semen are not associated with reduced HIV shedding

Journal of Immunology

Volumn 175, Issue 7, 2005, Pages 4789-4796

  Sheth, Prameet M ^a   Danesh, Ali ^a   Shahabi, Kamnoosh ^a   Mebbapragada, Anuradha ^a   Kovacs, Colin ^b   Dimayuga, Rowena ^b   Halpenny, Roberta ^b   MacDonald, Kelly S ^a,c   Mazzelli, Tony ^a,c   Kelvin, David ^a,e   Ostrowski, Mario ^a,d   Kaul, Rupert ^a,d,f  

^a UNIVERSITY OF TORONTO   (Canada)

^b Canadian Immunodeficiency Research Collaborative   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d Canadian Network for Vaccines and Immunotherapeutics   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; VIRUS RNA;

ANTIGEN SPECIFICITY; BLOOD SAMPLING; CELL COMPARTMENTALIZATION; CONFERENCE PAPER; ENZYME LINKED IMMUNOSPOT ASSAY; EPITOPE MAPPING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; PRIORITY JOURNAL; SEMEN ANALYSIS; SEXUALLY TRANSMITTED DISEASE; T LYMPHOCYTE ACTIVATION; VIRUS LOAD; VIRUS SHEDDING; VIRUS TRANSMISSION;

EID: 25444498269     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.7.4789     Document Type: Conference Paper

References (52)

1. Royce, R. A., A. Sena, W. Cates, Jr., and M. S. Cohen. 1997. Sexual transmission of HIV. N. Engl. J. Med. 336: 1072-1078.
2. Quinn, T. C., M. J. Wawer, N. Sewankambo, D. Serwadda, C. Li, F. Wabwire-Mangen, M. O. Meehan, T. Lutalo, and R. H. Gray. 2000. Viral load and heterosexual transmission of human immunodeficiency virus type 1: Rakai Project Study Group. N. Engl. J. Med. 342: 921-929.
3. Coombs, R. W., C. E. Speck, J. P. Hughes, W. Lee, R. Sampoleo, S. O. Ross, J. Dragavon, G. Peterson, T. M. Hooton, A. C. Collier, et al. 1998. Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. J. Infect. Dis. 177: 320-330.
4. Tachet, A., E. Dulioust, D. Salmon, M. De Almeida, S. Rivalland, L. Finkielsztejn, I. Heard, P. Jouannet, D. Sicard, and C. Rouzioux. 1999. Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission. AIDS 13: 823-831.
5. Bourlet, T., C. Cazorla, P. Berthelot, F. Grattard, F. Cognasse, A. Fresard, C. Defontaine, F. R. Lucht, C. Genin, and B. Pozzetto. 2001. Compartmentalization of HIV-1 according to antiretroviral therapy: viral loads are correlated in blood and semen but poorly in blood and saliva. AIDS 15: 284-285.
6. Coombs, R. W., P. S. Reichelderfer, and A. L. Landay. 2003. Recent observations on HIV type-1 infection in the genital tract of men and women. AIDS 17: 455-480.
7. Sheth, P., K. Shahabi, A. Rebbapragada, C. Kovacs, R. Dimayuga, S. Chakkalackal, K. MacDonald, T. Mazzulli, and R. Kaul. 2004. HIV viral shedding in semen: lack of correlation with systemic virus-specific CD8 responses. AIDS 18: 2202-2205.
8. Horton, H., T. Vogel, D. O'Connor, L. Picker, and D. I. Watkins. 2002. Analysis of the immune response and viral evolution during the acute phase of SIV infection. Vaccine 20: 1927-1932.
9. Leslie, A. J., K. J. Pfafferott, P. Chetty, R. Draenert, M. M. Addo, M. Feeney, Y. Tang, E. C. Holmes, T. Allen, J. G. Prado, et al. 2004. HIV evolution: CTL escape mutation and reversion after transmission. Nat. Med. 10: 282-289.
10. McMichael, A. J., and S. L. Rowland-Jones. 2001. Cellular immune responses to HIV. Nature 410: 980-987.
11. Musey, L., J. Hughes, T. Schacker, T. Shea, L. Corey, and M. J. McElrath. 1997. Cytotoxic-T cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N. Engl. J. Med. 337: 1267-1274.
12. Ogg, G. S., X. Jin, S. Bonhoeffer, P. R. Dunbar, M. A. Nowak, S. Monard, J. P. Segal, Y. Cao, S. L. Rowland-Jones, V. Cerundolo, et al. 1998. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279: 2103-2106.
13. + T cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75: 11983-11991.
14. Addo, M. M., X. G. Yu, A. Rathod, D. Cohen, R. L. Eldridge, D. Strick, M. N. Johnston, C. Corcoran, A. G. Wurcel, C. A. Fitzpatrick, et al. 2003. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 77: 2081-2092.
15. Shacklett, B. L., S. Cu-Uvin, T. J. Beadle, C. A. Pace, N. M. Fast, S. M. Donahue, A. M. Caliendo, T. P. Flanigan, C. C. Carpenter, and D. F. Nixon. 2000. Quantification of HIV-1-specific T cell responses at the mucosal cervicovaginal surface. AIDS 14: 1911-1915.
16. + cytotoxic T lymphocytes. J. Virol. 77: 291-300.
17. Musey, L., Y. Hu, L. Eckert, M. Christensen, T. Karchmer, and M. J. McElrath. 1997. HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women. J. Exp. Med. 185: 293-303.
18. + lymphocyte responses in the cervix of HIV-1 resistant prostitutes in Nairobi. J. Immunol. 164: 1602-1611.
19. Kaul, R., P. Thottingal, J. Kimani, P. Kiama, C. W. Waigwa, J. J. Bwayo, F. A. Plummer, and S. L. Rowland-Jones. 2003. Quantitative ex vivo analysis of functional virus-specific CD8 T lymphocytes in the blood and genital tract of HIV-infected women. AIDS 17: 1139-1144.
20. Quayle, A. J., W. M. Coston, A. K. Trocha, S. A. Kalams, K. H. Mayer, and D. J. Anderson. 1998. Detection of HIV-1-specific CTLs in the semen of HIV-infected individuals. J. Immunol. 161: 4406-4410.
21. Murphey-Corb, M., L. A. Wilson, A. M. Trichel, D. E. Roberts, K. Xu, S. Ohkawa, B. Woodson, R. Bohm, and J. Blanchard. 1999. Selective induction of protective MHC class I-restricted CTL in the intestinal lamina propria of rhesus monkeys by transient SIV infection of the colonic mucosa. J. Immunol. 162: 540-549.
22. + cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12. J. Clin. Invest. 102: 2072-2081.
23. Ma, Z. M., K. Abel, Y. C. Wang, and C. Miller. 2004. A period of transient viremia and occult infection precedes persistent viremia and anti-viral immune responses during multiple low-dose intravaginal SIV infections. In AidsVaccine 04, Lausanne, Switzerland, p. 37.
24. + T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200: 761-770.
25. + T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200: 749-759.
26. Clerici, M., C. Balotta, A. Salvaggio, C. Riva, D. Trabattoni, L. Papagno, A. Berlusconi, S. Rusconi, M. L. Villa, M. Moroni, and M. Galli. 1996. Human immunodeficiency virus (HIV) phenotype and interleukin-2/interleukin-10 ratio are associated markers of protection and progression in HIV infection. Blood 88: 574-579.
27. Rizzardini, G., D. Trabattoni, M. Saresella, S. Piconi, M. Lukwiya, S. Declich, M. Fabiani, P. Ferrante, and M. Clerici. 1998. Immune activation in HIV-infected African individuals: Italian-Ugandan AIDS cooperation program. AIDS 12: 2387-2396.
28. + T cells among HIV-infected individuals in south India. Int. J. STD AIDS. 11: 49-51.
29. McGowan, I., J. Elliott, M. Fuerst, P. Taing, J. Boscardin, M. Poles, and P. Anton. 2004. Increased HIV-1 mucosal replication is associated with generalized mucosal cytokine activation. J. Acquir. Immune Defic. Syndr. 37: 1228-1236.
30. Dunne, A. L., F. Mitchell, K. M. Allen, H. W. Baker, S. Garland, G. N. Clarke, A. Mijch, and S. M. Crowe. 2003. Analysis of HIV-1 viral load in seminal plasma samples. J. Clin. Virol. 26: 239-245.
31. Kaul, R., and S. L. Rowland-Jones. 1999. Methods of detection of HIV-specific CTL and their role in protection against HIV infection. In HIV Immunology Database. B. T. M. Korber, B. F. Haynes, R. Koup, C. Brander, J. P. Moore, B. D. Walker, and D. I. Watkins, eds. Theoretical Biology and Biophysics Group T-10, Los Alamos National Laboratory, Los Alamos, NM, p. IV 27-36.
32. + lymphocytes respond to different HIV epitopes in seronegative and infected subjects. J. Clin. Invest. 107: 1303-1310.
33. Morgan, E., R. Varro, H. Sepulveda, J. A. Ember, J. Apgar, J. Wilson, L. Lowe, R. Chen, L. Shivraj, A. Agadir, et al. 2004. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin. Immunol. 110: 252-266.
34. Pudney, J., and D. J. Anderson. 1995. Immunobiology of the human penile urethra. Am. J. Pathol. 147: 155-165.
35. + T cells to gut-associated lymphoid tissue during chronic infection. J. Virol. 77: 5621-5631.
36. Wolff, H., and D. J. Anderson. 1988. Immunohistologic characterization and quantitation of leukocyte subpopulations in human semen. Fertil. Steril. 49: 497-504.
37. Wolff, H., and D. J. Anderson. 1988. Male genital tract inflammation associated with increased numbers of potential human immunodeficiency virus host cells in semen. Andrologia 20: 404-410.
38. Barroso, P. F., M. Schechter, P. Gupta, M. F. Melo, M. Vieira, F. C. Murta, Y. Souza, and L. H. Harrison. 2000. Effect of antiretroviral therapy on HIV shedding in semen. Ann. Intern. Med. 133: 280-284.
39. Fiscus, S. A., P. L. Vernazza, B. Gilliam, J. Dyer, J. J. Eron, and M. S. Cohen. 1998. Factors associated with changes in HIV shedding in semen. AIDS Res. Hum. Retroviruses 14: S27-S31.
40. Vernazza, P. L., B. L. Gilliam, J. Dyer, S. A. Fiscus, J. J. Eron, A. C. Frank, and M. S. Cohen. 1997. Quantification of HIV in semen: correlation with antiviral treatment and immune status. AIDS 11: 987-993.
41. Speck, C. E., R. W. Coombs, L. A. Koutsky, J. Zeh, S. O. Ross, T. M. Hooton, A. C. Collier, L. Corey, A. Cent, J. Dragavon, et al. 1999. Risk factors for HIV-1 shedding in semen. Am. J. Epidemiol. 150: 622-631.
42. Betts, M. R., J. F. Krowka, T. B. Kepler, M. Davidian, C. Christopherson, S. Kwok, L. Louie, J. Eron, H. Sheppard, and J. A. Frelinger. 1999. Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors. AIDS Res. Hum. Retroviruses 15: 1219-1228.
43. + T cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. J. Virol. 76: 2298-2305.
44. Lieberman, J. 2004. Tracking the killers: how should we measure CD8 T cells in HIV infection? AIDS 18: 1489-1493.
45. + T-lymphocyte responses in blood and mucosa during chronic infection. J. Virol. 79: 4289-4297.
46. Shacklett, B. L., T. J. Beadle, P. A. Pacheco, J. H. Grendell, P. A. Haslett, A. S. King, G. S. Ogg, P. M. Basuk, and D. F. Nixon. 2000. Characterization of HIV-1-specific cytotoxic T lymphocytes expressing the mucosal lymphocyte integrin CD103 in rectal and duodenal lymphoid tissue of HIV-1-infected subjects. Virology 270: 317-327.
47. Groot, F., T. B. Geijtenbeek, R. W. Sanders, C. E. Baldwin, M. Sanchez-Hernandez, R. Floris, Y. van Kooyk, E. C. de Jong, and B. Berkhout. 2005. Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN-gp120 interaction. J. Virol. 79: 3009-3015.
48. Nduati, R., and G. John. 1995. Breast milk transmission of HIV-1. NARESA Mongr. 1-3.
49. Jana, N. K., L. R. Gray, and D. C. Shugars. 2005. Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity. J. Virol. 79: 6432-6440.
50. Farquhar, C., T. C. VanCott, D. A. Mbori-Ngacha, L. Horani, R. K. Bosire, J. K. Kreiss, B. A. Richardson, and G. C. John-Stewart. 2002. Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk. J. Infect. Dis. 186: 1173-1176.
51. Pillay, K., A. Coutsoudis, A. K. Agadzi-Naqvi, L. Kuhn, H. M. Coovadia, and E. N. Janoff. 2001. Secretory leukocyte protease inhibitor in vaginal fluids and perinatal human immunodeficiency virus type 1 transmission. J. Infect. Dis. 183: 653-656.
52. + T cell proliferation is coupled to perform expression and is maintained in nonprogressors. Nat. Immunol. 3: 1061-1068.